Gregg W. Stone, MD, had the unenviable task of condensing the 255-page agenda for next weekend’s Transcatheter Cardiovascular Therapeutics (TCT) meeting into a handful of highlights during a 12-minute media briefing on Thursday, Sept. 13.

Three decades after the first Transcatheter Cardiovascular Therapeutics conference, TCT.18’s organizers are moving “toward a more practical approach,” says Cardiovascular Research Foundation CEO Juan Granada, MD.

Daytime sleepiness and poor sleep patterns might be linked to hypertension in black women, researchers reported last week at the American Heart Association’s Joint Hypertension 2018 Scientific Sessions in Chicago. The same trial also connected excessive fatigue to inactivity and obesity.

Millimeter wave body scanners—standard security measures at airports, train stations and public buildings since the 2000s—are completely safe for heart patients with implantable devices, German researchers reported at last month’s ESC Congress.

Patients hospitalized with endocarditis can be safely switched from intravenous antibiotics to oral medication about halfway through the course of treatment, according to a randomized trial published in the New England Journal of Medicine.

Lorcaserin was associated with significant weight loss among overweight and obese individuals without compromising cardiovascular safety, according to a large, randomized trial published Aug. 26 in The New England Journal of Medicine and presented at the European Society of Cardiology (ESC) Congress in Munich.

A prevalence of left atrial fibrosis in endurance athletes could explain their increased risk for arrhythmias like atrial fibrillation (AFib), according to data presented this week at the European Society of Cardiology (ESC) Congress in Munich.

Late-breaking results of a trial presented at the European Society of Cardiology (ESC)’s 2018 meeting in Munich suggest a removable balloon is as effective as a permanent stent in unblocking small arteries. 

Late-breaking results from the VISION study, presented early this week at the European Society of Cardiology (ESC)’s annual symposium, found nearly three-quarters of patient deaths after noncardiac surgery can be attributed to cardiovascular causes.

Preliminary results from a European Society of Cardiology (ESC) poll suggest the best long-term investment medical institutions can make is in their own employees, whose risk for burnout could be mitigated by more dynamic, supportive work environments where they feel valued.

Cardiac patients diagnosed with “broken heart syndrome” are twice as likely to run into clinical complications during treatment if they have a history of cancer, Italian researchers reported this week at the ESC Congress in Munich.

Research presented this week at the European Society of Cardiology Congress in Munich suggests a new treatment may be emerging for transthyretin amyloid cardiomyopathy—a condition previously thought to be rare and untreatable.